Weight loss drug tirzepatide may lower the risk of diabetic retinopathy
The popular diabetes and weight loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of…
High adherence and safety found in short TB treatments
A study comparing one- and three-month antibiotic treatments to prevent active tuberculosis (TB) finds that a high percentage…
University of Missouri launches first on-campus radiopharmaceutical clinical trial
In a major leap for cancer care at the University of Missouri, the School of Medicine and MU…
Tirzepatide shows dual benefits in sleep apnea trial improving metabolism and reducing inflammation
New clinical trial evidence suggests targeting both obesity and sleep-disordered breathing together may reshape cardiometabolic risk management in…
High-dose motor therapy improves outcomes after perinatal stroke
In infants and toddlers who had a stroke before birth or as a newborn (28 days or younger),…
Tumor-targeted chimeric drug increases efficacy and limits side effects
Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more…
RNA micelles enable targeted chemotherapy without immune toxicity
A new study in mice hints at the potential to use tiny particles made with RNA molecules to…
Does motherhood influence brain aging? New research suggests a positive cognitive association
New longitudinal evidence suggests reproductive history may shape women’s cognitive aging, offering insights into possible protective pathways while…
Artificial lung keeps patient alive after lung removal
By replacing both breathing and circulatory buffering, a novel artificial lung bought critical time after lung removal, revealed…
Immune scaffold predicts onset weeks early
A retrievable immune scaffold reveals a 5–7 week presymptomatic window for tracking type 1 diabetes progression, long before…
Wellness Studio offers mental health support in welcoming environment
BATON ROUGE, La. (WAFB) – Going to the gym and eating well are critical to your health. So…
Palbociclib improves progression-free survival in HER2 positive breast cancer
PrECOG, LLC, today announced the publication of final results from the pivotal phase 3 PATINA study in the…